Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Autoimmune disease].

Toshikazu Yoshikawa¹, Yutaka Kawahito

¹Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|April 15, 2005

Summary

Peroxisome proliferator-activated receptors (PPARs) ligands show potential for treating autoimmune diseases by suppressing inflammation and regulating immune responses. These nuclear receptors offer therapeutic possibilities for various immune-related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men.

Frontiers in physiology·2013

Same author

Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines.

Oncology reports·2013

Same author

SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.

Cancer science·2013

Same author

Role of metallothionein in murine experimental colitis.

International journal of molecular medicine·2013

Same author

BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1.

Inflammatory bowel diseases·2013

Same author

Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer.

International journal of cancer·2013

Area of Science:

Molecular biology
Endocrinology
Immunology

Context:

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors regulating physiological processes.
PPAR-alpha and PPAR-gamma subtypes possess significant anti-inflammatory properties.
These receptors are crucial for maintaining immune system balance.

Purpose:

To review the anti-inflammatory and immunoregulatory functions of PPARs.
To explore the therapeutic utility of PPAR ligands in autoimmune disease models.
To assess the potential application of PPAR ligands in treating human autoimmune diseases.

Summary:

PPARs are ligand-activated transcription factors with diverse physiological roles, including fatty acid regulation.
PPAR-alpha and -gamma ligands demonstrate anti-inflammatory effects and modulate immune cell activity.
Studies in autoimmune disease models indicate the potential of PPAR ligands as therapeutic agents.

Impact:

PPAR ligands can suppress inflammation and correct aberrant immune reactions.
This review highlights the promise of PPAR-based therapies for autoimmune disorders.
PPARs represent a potential therapeutic target for managing human autoimmune diseases.

Related Experiment Videos